Next Article in Journal
Causal Relationship Between Sjögren’s Syndrome and Gut Microbiota: A Two-Sample Mendelian Randomization Study
Next Article in Special Issue
Osteopontin and Clinical Outcomes in Hemodialysis Patients
Previous Article in Journal
A Clinical Evaluation of the Role of Autoimmunity in the Relation Between Erosions and Bone Mineral Density in Rheumatoid Arthritis
 
 
Review
Peer-Review Record

Dyslipidemia in Peritoneal Dialysis: Implications for Peritoneal Membrane Function and Patient Outcomes

Biomedicines 2024, 12(10), 2377; https://doi.org/10.3390/biomedicines12102377
by Natalia Stepanova 1,2
Reviewer 2: Anonymous
Biomedicines 2024, 12(10), 2377; https://doi.org/10.3390/biomedicines12102377
Submission received: 21 September 2024 / Accepted: 16 October 2024 / Published: 17 October 2024
(This article belongs to the Special Issue Emerging Trends in Kidney Disease)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

Very interesting subject

the review aims to summarize the current knowledge on the pathophysiology of dyslipidemia in patients with PD, elucidate the molecular mechanisms linking dyslipidemia to peritoneal membrane dysfunction, and discuss the clinical implications of these interactions.

It also evaluates current data on potential therapeutic strategies for managing dyslipidemia in patients undergoing PD, with a focus on enhancing peritoneal membrane integrity and function, as well as improving overall patient outcomes.

The article is very well structured, clear, concise. The presentation of the subject is done in an extremely complex manner, with useful details for daily practice. Relevant conclusions. The current bibliography is extremely relevant for the topic addressed

Reviewer 2 Report

Comments and Suggestions for Authors

This paper overviews the current knowledge on the pathophysiology of dyslipidemia in peritoneal dialysis, reviews potential molecular mechanisms linking dyslipidemia to peritoneal membrane dysfunction, and discusses the clinical implications of these interactions. It evaluates potential therapeutic strategies for managing dyslipidemia in patients undergoing peritoneal dialysis to improve overall patient outcomes.

This work represents a high-quality review and will likely have an important impact in this field.

Back to TopTop